Frontiers: University of Kansas Clinical and Translational Science Institute
Frontiers: University of Kansas Clinical and Translational Science Institute
批准号:
9514338
负责人:
Richard J. Barohn
金额:
$406.37万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-07 至 2022-06-30
关键词:
AcademiaAddressAdvocacyAdvocateAfrican AmericanAmerican IndiansAutomobile DrivingAwardBirthChildhoodCitiesClinicClinicalClinical ResearchCollaborationsCommunitiesCompetenceComplexDataData AnalysesDecision MakingDevelopmentDisciplineDiseaseElderlyElectronic Health RecordEnsureEntrepreneurshipEthicsFundingGenerationsGoalsGood Clinical PracticeGovernmentHealthHealth SciencesHealthcareIndividualIndustryInformaticsInformation DisseminationInstitutesInstitutionInstitutional Review BoardsInterdisciplinary StudyKansasKnowledgeLatinoLeadLeadershipLinkLongevityMedicalMedical DeviceMedical InformaticsMedical centerMethodsMidwestern United StatesParticipantPatientsPharmaceutical PreparationsPilot ProjectsPopulation HeterogeneityPositioning AttributePrisonsProcessRare DiseasesRecruitment ActivityRegistriesResearchResearch DesignResearch InfrastructureResearch PersonnelResearch SupportResearch TrainingResource InformaticsResourcesRural PopulationScienceScientific Advances and AccomplishmentsServicesTexasTrainingTraining ProgramsTranslatingTranslational ResearchUniversitiesVisionWorkforce Developmentbasecatalystclinical carecommunity partnershipdrug discoveryend of lifefrontierimplementation researchimprovedindustry partnerinnovationmulti-site trialmultidisciplinarynext generationnovelnovel strategiespatient orientedpoint of carepopulation healthprecision medicineproduct developmentprogramssupport toolstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Contact PD/PI: Barohn, Richard Joel
OVERALL: ABSTRACT
Frontiers: The Heartland Institute for Clinical and Translational Research has been a catalyst for bringing
together translational science investigators and stakeholders across the KC region, and beyond. Located
at the University of Kansas Medical Center (KUMC) under the leadership of Dr. Barohn, our commitment
to team science and multidisciplinary collaboration reaches beyond the walls of our academic health
science center and promotes collaboration among investigators from diverse disciplines across local
partner academic institutions and affiliated health care institutions. The vision of Frontiers is to contribute
to and lead national efforts to transform the way we do clinical and translational research (CTR), and to
ensure research is more rapidly and more efficiently translated to the point of care so that it may contribute
to improved health. Specifically, Frontiers aims to: 1) Engage in bi-directional collaboration with all
stakeholders to develop, demonstrate, and disseminate advances across the translational science
spectrum that insures inclusion and integration of complex and diverse populations and individuals across
the lifespan from birth to end of life; 2) Create a sustainable translational workforce of multi-disciplinary
investigators, research personnel, and community and patient stakeholders in the use of translational
science tools through innovative and creative programs; and 3) Strengthen institutional and regional
infrastructure to accelerate translational research. We will accomplish these aims by drawing on our
considerable strengths: a) developing informatics tools for making EHR data `research ready' and
implementing clinic- and community-based registries for study recruitment and other translational research
applications; b) nurturing and sustaining strong patient and community engagement relationships that will
support research with African American, Latino, American Indian, LGBTQ, pediatric, geriatric, rare
disease, prison, and rural populations; c) offering innovative training programs for the entire CTR
workforce (not just investigators), including plans for comprehensive entrepreneurship and implementation
research training and creating new team science brainstorming mechanisms that will lead to
multidisciplinary discovery projects and d) advancing medical devices and re-purposed drugs to patients
through novel strategies developed by Frontiers' Institute for Advancing Medical Innovations (IAMI)that is
nationally known for its product development translational research and high impact collaborations with
industry, academia, government, and disease philanthropy partners. All Frontiers units are linked by a
group of Navigators that can be accessed by Frontiers investigative teams and community partners.
These plans position Frontiers to contribute to goals, and lead initiatives of the CTSA network by building
on technological, computational, and health/disease knowledge to advance translational research.
Project Summary/Abstract Page 274
Contact PD/PI: Barohn, Richard Joel
OVERALL NARRATIVE
Frontiers: The Heartland Institute for Clinical and Translational Research provides infrastructure and
educational programs to develop the next generation of CTR investigative teams. As a regional organization
involving two states and three universities, Frontiers is able to blend the best resources available to advance
team, community and clinical translational science. This results in accelerating discoveries and research
findings that may be more rapidly brought to the point of care and contribute to population health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:9560956
-
项目类别:
-
资助金额:$402.38万
-
财政年份:2017
-
负责人:Richard J. Barohn
-
依托单位:
Models of Neuromuscular Disease Across the Lifespan
-
批准号:9195818
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2016
-
负责人:Richard J. Barohn
-
依托单位:
A Phase II Trial of Rituximab In Myasthenia Gravis
-
批准号:8644497
-
项目类别:
-
资助金额:$130.54万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8569903
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8683099
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
A Phase II Trial of Rituximab In Myasthenia Gravis
-
批准号:8731286
-
项目类别:
-
资助金额:$105.9万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:9341908
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:10242456
-
项目类别:
-
资助金额:$10.58万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8355588
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8543461
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:9132606
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Unit for Neuroscience Trials
-
批准号:8242137
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8270452
-
项目类别:
-
资助金额:$319.78万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8365250
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8365247
-
项目类别:
-
资助金额:$185.55万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8473932
-
项目类别:
-
资助金额:$310.84万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
-
批准号:8365246
-
项目类别:
-
资助金额:$83.5万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Unit for Neuroscience Trials
-
批准号:8337820
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8262012
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8869066
-
项目类别:
-
资助金额:$63.22万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
海外基金